Pharma News
-
World’s first study to prove myopia prevention in children by low-concentration atropine drops
Pharma | News | 0 Comment | 14 Mar, 2023
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) conducted a randomised, placebo-con...Read more
-
GHIT Fund invests ¥ 260 M for new malaria drug development by Japanese firms
Pharma | News | 0 Comment | 13 Mar, 2023
The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 2...Read more
-
Elevating Life science industry standards through the implementation of quality practices
Pharma | Analysis | 0 Comment | 10 Mar, 2023
Lifescience Laboratory workflows, products and services are complex and can be difficult to manage due to long and strin...Read more
-
Australia's Starpharma names Justin Cahill as Chief Financial Officer and Company secretary
Pharma | News | 0 Comment | 10 Mar, 2023
Australian firm Starpharma Holdings has announced the appointment of Justin Cahill as Chief Financial Officer (CFO)...Read more
-
Japanese firm Sumitomo invests in radiopharmaceutical startup Alpha Fusion
Pharma | News | 0 Comment | 09 Mar, 2023
Japan-based Sumitomo Heavy Industries (SHI) has announced the decision to invest in Alpha Fusion Inc. (AF), a developer ...Read more
-
China's Biocytogen partners with Janssen for discovery of new antibody-based drugs
Pharma | News | 0 Comment | 09 Mar, 2023
China-based Biocytogen Pharmaceuticals has announced the signing of a non-exclusive license agreement with Janssen Biote...Read more
-
Japan's Teijin Pharma inks $230 M deal with Novartis for kidney diseases treatment
Pharma | News | 0 Comment | 08 Mar, 2023
Teijin Pharma, based in Japan, has entered into an exclusive global license agreement with Swiss firm Novartis t...Read more
-
Kyorin and Sumitomo to introduce drug for overactive bladder in Taiwan & other Asian countries
Pharma | News | 0 Comment | 07 Mar, 2023
Kyorin Pharmaceutical, a subsidiary of Kyorin Holdings, Inc. and Sumitomo Pharma, in Japan, have entered into a license ...Read more
-
Pharma | Analysis | By Sanjiv Das | 0 Comment | 06 Mar, 2023
The word layoff is accustomed to us and many companies across the globe take part in this exercise. Excuses like global ...Read more
-
Biogen terminates multiple sclerosis (MS) pact with Eisai in Japan
Pharma | News | 0 Comment | 03 Mar, 2023
Biogen Japan and Eisai have announced the termination of the co-promotion agreement that has been in place since January...Read more
-
CPHI & PMEC China 2023 to attract over 55,000 visitors on 19-21 June
Pharma | News | 0 Comment | 02 Mar, 2023
In 2023, CPHI & PMEC China will be held in 19-21 June 2023 at SNIEC (Shanghai New International Expo Centre), Shangh...Read more
-
Deprecated Yen attracts renewed international interest in Japanese pharma
Pharma | News | 0 Comment | 01 Mar, 2023
CPHI Japan 2023 opens in April (19-21) as the country undergoes a huge resurgence in international trade, with West...Read more
-
Korea's GC Biopharma buys rare disease pipeline in haematology from Catalyst Biosciences
Pharma | News | 0 Comment | 28 Feb, 2023
GC Biopharma, a leading provider of biopharmaceutical products in South Korea, has signed an Asset Purchase Agreement wi...Read more
-
Korea's diabetes drug Envlo to enter $1.54 B market in Brazil and Mexico
Pharma | News | 0 Comment | 01 Mar, 2023
South Korean firm Daewoong Pharmaceutical has announced the launching of their national new drug #36, 'Envlo (ingredient...Read more
-
Taiwan approves Ono Pharma's non-small cell lung cancer drug with chemotherapy
Pharma | News | 0 Comment | 24 Feb, 2023
Japanese firm Ono Pharmaceutical has received the approval of Opdivo (nivolumab) Intravenous Infusion, a human anti-hu...Read more
-
South Australian Government takes new initiatives to develop biomanufacturing sector
Pharma | News | 0 Comment | 22 Feb, 2023
Biomanufacturing sector will be given a boost by the South Australian Government’s announcement of new initiatives...Read more
-
Japanese pharma firm Eisai dissolves joint venture with Italy's Bracco Imaging
Pharma | News | 0 Comment | 21 Feb, 2023
Bracco Imaging S.p.A. (Headquartered in Milan, Italy) and Japan based pharmaceutical firm Eisai Co. have announced that ...Read more
-
Capricor Therapeutics inks $100 M deal with Nippon Shinyaku for DMD treatment in Japan
Pharma | News | 0 Comment | 20 Feb, 2023
US-based biotech firm Capricor Therapeutics has entered into a partnership with Nippon Shinyaku Co., a Japanese pharmace...Read more
